Literature DB >> 2895064

Contrasuppression and tumor rejection.

P M Flood1, A Friedman, B Horvat, P Reuter, A Rodriquez, W Ptak.   

Abstract

The growth of a highly progressive MCA-induced tumor 3152-PRO is dependent on the activity of suppressor T cells (Ts). Injection of syngeneic mice with antibodies specific for Ts leads to enhanced tumor transplantation resistance of the 3152-PRO tumor. In addition, injection of recipient mice with highly immunogenic regressor tumors conjugated with trinitrophenyl (TNP) activates a T cell population which also mediates protection to transplantation of TNP-conjugated 3152-PRO tumor cells. One such tumor, 1591-RE, was investigated in detail to determine the phenotype and biologic activity of this T cell population in overcoming Ts cell activity. Induction of transplantation resistance requires the presence of TNP hapten on both the highly regressive immunizing tumor (and not its progressor variant 1591-PRO4), and on the challenge tumor 3152-PRO. The cell population from TNP-1591-RE immunized animals which mediates protection against the transplantation of TNP-3152-PRO is Thy-1+, CD4+, 8-, Lyt1+, I-J+, and Vicia villosa lectin adherent, the identical phenotype to antigen-specific contrasuppressor T cells in the contact sensitivity (CS) response to TNP in vivo. A T cell population of identical phenotype from TNP-1591-RE immunized mice can overcome the effects of antigen-specific Ts cells on PCl-immune cells in the adoptive transfer of CS in vivo. These results suggest that immunoregulatory cells that mediate protection against progressive tumors may be identical in function to antigen-specific contrasuppressor T cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2895064     DOI: 10.1016/0165-2478(87)90161-1

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  2 in total

1.  Generation of a T-cell hybridoma producing a contrasuppressor factor for contact sensitivity.

Authors:  A M Friedman; W Ptak; E Brewer; D R Green; P A Reuter; P M Flood
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

2.  Marking hypoxic cells for complement and cytotoxic T lymphocyte-mediated lysis: using pimonidazole.

Authors:  S C Chou; P M Flood; J A Raleigh
Journal:  Br J Cancer Suppl       Date:  1996-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.